Therapeutic indications and metabolic effects of metreleptin in patients with lipodystrophy syndromes: Real‐life experience from a national reference network

202238 citationsJournal Articlehybrid Open Access

Authors

Héléna Mosbah · Inserm

Marie‐Christine Vantyghem · Inserm

Estelle Nobécourt · Centre Hospitalier Universitaire de La Réunion

Fabrizio Andréelli · Inserm

F. Archambeaud · Hôpital Dupuytren

Élise Bismuth · Université Paris Cité

Claire Briet ·

Abstract

In this real-life setting study, metabolic outcomes are improved by metreleptin therapy in patients with GLD. The therapeutic indication for metreleptin needs to be clarified in patients with PLD.

Topics & Keywords

Nuclear Structure and Function Metabolism, Diabetes, and Cancer RNA and protein synthesis mechanisms

Publication Details

Published in: Diabetes Obesity and Metabolism

Volume 24, Issue 8, pp. 1565-1577

DOI: 10.1111/dom.14726

Field-Weighted Citation Impact: 3.21

Command Palette

Therapeutic indications and metabolic effects of metreleptin in patients with lipodystrophy syndromes: Real‐life experience from a national reference network

Authors

Abstract

Topics & Keywords

Publication Details